Gentis news

Newborn screening is one of the crucial steps in healthcare that helps detect congenital disorders early in a child's life. Early detection not only allows for early intervention but also helps minimize the risk of complications and limit the impact on physical and intellectual development in the future.

Pregnancy and childbirth are among the most sacred journeys in a woman’s life. However, alongside the happiness of preparing to welcome a little angel, many expectant mothers still feel anxious about labor, childbirth pain, and the physical changes that occur during delivery. Therefore, being well-equipped with prenatal knowledge plays an extremely important role in helping mothers feel more confident mentally and physically on the day of childbirth.

SECOND UPDATED NOTICE Regarding the impersonation of Eurofins GENTIS employees requesting customers to transfer shipping fees for newborn screening test results

PGT (Preimplantation Genetic Testing) is a genetic analysis performed before embryo transfer to help select the best embryos - those without abnormalities in chromosome number or structure, or without disease-causing genetic mutations - for embryo transfer. So, how is the PGT process carried out in IVF treatment?

Preimplantation Genetic Testing (PGT) is becoming an essential tool for improving IVF success rates and reducing the risk of genetic abnormalities. Eurofins GENTIS offers a comprehensive portfolio of PGT tests, utilizing advanced technologies to support the selection of healthy embryos and optimize the journey to parenthood.

On April 28, 2026, at Hanoi Obstetrics and Gynecology Hospital, Eurofins Genetic Testing Service Joint Stock Company held a scientific seminar and professional exchange with doctors, specialists, and midwives from the hospital’s department of assisted reproduction & andrology. The session focused on updating in-depth knowledge about PGT-M testing - one of the key tests in assisted reproduction, which helps screen embryos for single-gene genetic disorders before embryo transfer.

On April 24, 2026, Eurofins GENTIS organized an internal training program on Clinmind software for interpreting newborn screening test results, led directly by Dr. Nguyen Huy Dong – R&D specialist of the company. This activity is part of the strategy to enhance professional capacity, standardize analysis and data interpretation processes, and promote the application of advanced technologies in genetic screening and diagnosis.